In December, a jury awarded Lynn Hartman $1.8 million in compensatory damages and $26 million in punitive damages after she claimed taking Xarelto for her atrial fibrillation caused gastrointestinal bleeding. The lawsuit is just one of nearly 21,400 Johnson & Johnson and Bayer AG are facing over Xarelto, but this was the first to award any damages.
In three previous cases, federal judges cleared the companies of any liability. Both companies noted the drug’s label adequately warns customers of any internal bleeding risk.
More articles on legal and regulatory issues:
Florida physician charged with sexually assaulting woman during colonoscopy: 5 things to know
1 of 12 fired Missouri hospital employees files lawsuit for wrongful termination
Hospital groups to appeal lawsuit dismissal that permits $1.6B in Medicare payment cuts
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.